Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responses

OncoImmunology

Volumn 3, Issue 5, 2014, Pages

  Wachowska, Malgorzata ^a   Gabrysiak, Magdalena ^a   Golab, Jakub ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PHYSICAL CHEMISTRY   (Poland)

Author keywords

5 aza 2' deoxycitidine; Cancer; Epigenetic; Methyltransferase; Photodynamic therapy; Tumor immunology; Tumor associated antigens

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE INHIBITOR; P1A ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; DOWN REGULATION; DRUG MECHANISM; EPIGENETIC REMODELING; EPIGENETICS; GENE SILENCING; HUMAN; MYELODYSPLASTIC SYNDROME; NONHUMAN; PHOTODYNAMIC THERAPY; TUMOR CELL; TUMOR ESCAPE; TUMOR IMMUNITY;

EID: 84904035016     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.28837     Document Type: Article

References (10)

1. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011; 61:250-81; PMID:21617154; http://dx.doi.org/10.3322/caac.20114
2. Nowis D, Makowski M, Stokłosa T, Legat M, Issat T, Gołab J. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 2005; 52:339-52; PMID:15990919
3. Nowis D, Stoklosa T, Legat M, Issat T, Jakobisiak M, Golab J. The influence of photodynamic therapy on the immune response. Photodiagn Photodyn Ther 2005; 2:283-98; http://dx.doi.org/10.1016/S1572-1000(05)00098-0
4. Korbelik M, Krosl G, Krosl J, Dougherty GJ. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res 1996; 56:5647-52; PMID:8971170
5. Korbelik M, Cecic I. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett 1999; 137:91-8; PMID:10376798; http://dx.doi.org/10.1016/S0304-3835(98)00349-8
6. Mroz P, Vatansever F, Muchowicz A, Hamblin MR. Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A. Cancer Res 2013; 73:6462-70; PMID:24072749; http://dx.doi.org/10.1158/0008-5472.CAN-11-2572
7. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188:22-32; PMID:12445278; http://dx.doi.org/10.1034/j.1600-065X.2002.18803.x
8. Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Kitchener HC, Hampson IN. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res 2001; 61:192-6; PMID:11196160
9. Guo ZS, Hong JA, Irvine KR, Chen GA, Spiess PJ, Liu Y, Zeng G, Wunderlich JR, Nguyen DM, Restifo NP, et al. De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res 2006; 66:1105-13; PMID:16424047; http://dx.doi.org/10.1158/0008-5472.CAN-05-3020
10. Wachowska M, Gabrysiak M, Muchowicz A, Bednarek W, Barankiewicz J, Rygiel T, Boon L, Mroz P, Hamblin MR, Golab J. 5-Aza-2′-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy. Eur J Cancer 2014; 50:1370-81; PMID:24559534; http://dx.doi.org/10.1016/j.ejca.2014.01.017